CLU and breast cancer: Using this methodology, we identified nine proteins—FN1, VWF, PRG4, MMP9, CLU, PRDX6, PPBP (CXCL7), APOC1, and CHL1—that were robustly quantified in serum and showed statistically significant differences between breast cancer patients and healthy controls.